Current Cancer Drug Targets, Volume 8 - Number 5

FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

, 8(5): 342 - 348

D. L. Cortinovis, F. Andriani, A. Livio, A. Fabbri, F. Perrone, B. Marcomini, S. Pilotti, L. Mariani, P. Bidoli, E. Bajetta, L. Roz and G. Sozzi

DOI: 10.2174/156800908785133204

Targeting Angiogenesis in Renal Cell Carcinoma

, 8(5): 349 - 358

Georgios Lainakis and Aristotle Bamias

DOI: 10.2174/156800908785133132

Molecular Targets in Gastrointestinal Stromal Tumors (GIST) Therapy

, 8(5): 359 - 366

C. Braconi, R. Bracci and R. Cellerino

DOI: 10.2174/156800908785133169

Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer

, 8(5): 367 - 377

George G. Chen, Alexander C. Vlantis, Qiang Zeng and C. Andrew van Hasselt

DOI: 10.2174/156800908785133150

Novel Epigenetic Targets in Lymphoproliferative Disorders

, 8(5): 378 - 391

Julio Delgado

DOI: 10.2174/156800908785133222

Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer

, 8(5): 392 - 403

Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome

DOI: 10.2174/156800908785133187

The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion

, 8(5): 404 - 413

Yih-Wen Chen, Christina Tekle and Oystein Fodstad

DOI: 10.2174/156800908785133141

Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy

, 8(5): 414 - 420

A. Gradilone, F. M. Pulcinelli, L. V. Lotti, E. Trifiro, S. Martino, O. Gandini, W. Gianni, L. Frati, A. M. Agliano and P. Gazzaniga

DOI: 10.2174/156800908785133178

NUPR1 Interacts with p53, Transcriptionally Regulates p21 and Rescues Breast Epithelial Cells from Doxorubicin-Induced Genotoxic Stress

, 8(5): 421 - 430

David W. Clark, Aparna Mitra, Rebecca A. Fillmore, Wen G. Jiang, Rajeev S. Samant, Oystein Fodstad and Lalita A. Shevde

DOI: 10.2174/156800908785133196

Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression – the Concept of Committed Progenitor Cells

, 8(5): 431 - 445

K. Agelopoulos, H. Buerger and B. Brandt

DOI: 10.2174/156800908785133213

Webmaster Contact:
Copyright © 2018 Bentham Science